Overview

A Single Center 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate which pain mechanisms that can be affected by etoricoxib compared to placebo (inactive medication)in subjects with painful knee osteoarthritis af 4 weeks of treatment.

Phase:

Phase 2

Details

Lead Sponsor:

C4Pain

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Etoricoxib